LifeMD Inc’s recently made public that its Chief Financial Officer Benathen Marc David unloaded Company’s shares for reported $0.98 million on Jun 16 ’25. In the deal valued at $13.09 per share,75,000 shares were sold. As a result of this transaction, Benathen Marc David now holds 389,554 shares worth roughly $5.31 million.
Then, Benathen Marc David sold 50,000 shares, generating $700,495 in total proceeds. Upon selling the shares at $14.01, the Chief Financial Officer now owns 339,554 shares.
Before that, Yecies Eric Harold sold 15,000 shares. LifeMD Inc shares valued at $183,750 were divested by the Chief Legal Officer & GC at a price of $12.25 per share. As a result of the transaction, Yecies Eric Harold now holds 16,100 shares, worth roughly $0.22 million.
BTIG Research reiterated its LifeMD Inc [LFMD] rating to a Buy in a research note published on June 18, 2025; the price target was $18. A number of analysts have revised their coverage, including Lake Street’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Mizuho began covering LFMD with “Neutral” recommendation on December 04, 2024.
Price Performance Review of LFMD
On Monday, LifeMD Inc [NASDAQ:LFMD] saw its stock fall -0.95% to $13.62. Over the last five days, the stock has lost -4.76%. LifeMD Inc shares have risen nearly 96.25% since the year began. Nevertheless, the stocks have risen 175.15% over the past one year. While a 52-week high of $15.84 was reached on 06/23/25, a 52-week low of $3.99 was recorded on 03/10/25.
Levels Of Support And Resistance For LFMD Stock
The 24-hour chart illustrates a support level at 13.34, which if violated will result in even more drops to 13.05. On the upside, there is a resistance level at 14.17. A further resistance level may holdings at 14.71.
How much short interest is there in LifeMD Inc?
A steep rise in short interest was recorded in LifeMD Inc stocks on 2025-06-13, dropping by -0.29 million shares to a total of 3.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.86 million shares. There was a decline of -8.04%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 05, 2024 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $12 price target.
